CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes

Current Opinion in Immunology

Volumn 23, Issue 6, 2011, Pages 739-745

  Haskins, Kathryn ^a   Cooke, Anne ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AUTOANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; CHROMOGRANIN A; GAMMA INTERFERON; INSULIN; INTERLEUKIN 17; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL MIGRATION; CELL TRANSFER; DEAMINATION; DENDRITIC CELL; EFFECTOR CELL; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PROTEIN MODIFICATION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL;

ANIMALS; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; HISTOCOMPATIBILITY ANTIGENS; HUMANS; RECEPTORS, ANTIGEN, T-CELL;

EID: 82955211453     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.08.004     Document Type: Review

References (55)

1. Haskins K. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv Immunol 2005, 87:123-162.
2. Katz J.D., Wang B., Haskins K., Benoist C., Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993, 74:1089-1100.
3. Ma D.Y., Clark E.A. The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol 2009, 21:265-272.
4. Peters A.L., Stunz L.L., Bishop G.A. CD40 and autoimmunity: the dark side of a great activator. Semin Immunol 2009, 21:293-300.
5. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001, 19:225-252.
6. Bour-Jordan H., Esensten J.H., Martinez-Llordella M., Penaranda C., Stumpf M., Bluestone J.A. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol Rev 2011, 241:180-205.
7. Wagner D.H., Newell E., Sanderson R.J., Freed J.H., Newell M.K. Increased expression of CD40 on thymocytes and peripheral T cells in autoimmunity: a mechanism for acquiring changes in the peripheral T cell receptor repertoire. Int J Mol Med 1999, 4:231-242.
8. Wagner D.H., Vaitaitis G., Sanderson R., Poulin M., Dobbs C., Haskins K. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc Natl Acad Sci U S A 2002, 99:3782-3787.
9. Munroe M.E., Bishop G.A. A costimulatory function for T cell CD40. J Immunol 2007, 178:671-682.
10. Baker R.L., Wagner D.H., Haskins K. CD40 on NOD CD4 T cells contributes to their activation and pathogenicity. J Autoimmun 2008, 31:385-392.
11. + auto-aggressive T cell expansion during insulin-dependent diabetes mellitus. Eur J Immunol 2004, 34:1488-1497.
12. Munroe M.E. Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis. Semin Immunol 2009, 21:283-288.
13. Morel P.A., Srinivas M., Turner M.S., Fuschiotti P., Munshi R., Bahar I., Feili-Hariri M., Ahrens E.T. Gene expression analysis of dendritic cells that prevent diabetes in NOD mice: analysis of chemokines and costimulatory molecules. J Leukoc Biol 2011.
14. Chou F.C., Shieh S.J., Sytwu H.K. Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol 2009, 39:2403-2411.
15. Wei J., Loke P., Zang X., Allison J.P. Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity. J Exp Med 2011, 208:1683-1694.
16. Grinberg-Bleyer Y., Saadoun D., Baeyens A., Billiard F., Goldstein J.D., Gregoire S., Martin G.H., Elhage R., Derian N., Carpentier W., et al. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J Clin Invest 2010, 120:4558-4568.
17. Luo X., Herold K.C., Miller S.D. Immunotherapy of type 1 diabetes: where are we and where should we be going?. Immunity 2010, 32:488-499.
18. Jain R., Tartar D.M., Gregg R.K., Divekar R.D., Bell J.J., Lee H.H., Yu P., Ellis J.S., Hoeman C.M., Franklin C.L., et al. Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J Exp Med 2008, 205:207-218.
19. Emamaullee J.A., Davis J., Merani S., Toso C., Elliott J.F., Thiesen A., Shapiro A.M. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009, 58:1302-1311.
20. van den Brandt J., Fischer H.J., Walter L., Hunig T., Kloting I., Reichardt H.M. Type 1 diabetes in BioBreeding rats is critically linked to an imbalance between Th17 and regulatory T cells and an altered TCR repertoire. J Immunol 2010, 185:2285-2294.
21. Ankathatti Munegowda M., Deng Y., Chibbar R., Xu Q., Freywald A., Mulligan S.J., van Drunen Littel-van den Hurk S., Sun D., Xiong S., Xiang J. A distinct role of CD4(+) Th17- and Th17-Stimulated CD8(+) CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis. J Clin Immunol 2011.
22. Bertin-Maghit S., Pang D., O'Sullivan B., Best S., Duggan E., Paul S., Thomas H., Kay T.W., Harrison L.C., Steptoe R., et al. Interleukin-1beta produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy. Diabetes 2011, 60:248-257.
23. Zhu J., Paul W.E. Heterogeneity and plasticity of T helper cells. Cell Res 2010, 20:4-12.
24. Martin-Orozco N., Chung Y., Chang S.H., Wang Y.H., Dong C. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 2009, 39:216-224.
25. Bending D., De la Pena H., Veldhoen M., Phillips J.M., Uyttenhove C., Stockinger B., Cooke A. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009, 119:565-572.
26. Lexberg M.H., Taubner A., Forster A., Albrecht I., Richter A., Kamradt T., Radbruch A., Chang H.D. Th memory for interleukin-17 expression is stable in vivo. Eur J Immunol 2008, 38:2654-2664.
27. Lexberg M.H., Taubner A., Albrecht I., Lepenies I., Richter A., Kamradt T., Radbruch A., Chang H.D. IFN-gamma and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur J Immunol 2010, 40:3017-3027.
28. Bending D., Newland S., Krejci A., Phillips J.M., Bray S., Cooke A. Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J Immunol 2011, 186:3373-3382.
29. Nistala K., Adams S., Cambrook H., Ursu S., Olivito B., de Jager W., Evans J.G., Cimaz R., Bajaj-Elliott M., Wedderburn L.R. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 2010, 107:14751-14756.
30. Lennon G.P., Bettini M., Burton A.R., Vincent E., Arnold P.Y., Santamaria P., Vignali D.A. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 2009, 31:643-653.
31. Calderon B., Carrero J.A., Miller M.J., Unanue E.R. Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc Natl Acad Sci U S A 2011, 108:1561-1566.
32. Lieberman S.M., DiLorenzo T.P. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 2003, 62:359-377.
33. Babad J., Geliebter A., DiLorenzo T.P. T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes. Immunology 2010, 131:459-465.
34. Moser A., Hsu H.T., van Endert P. Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets, F1000. Biol Rep 2010, 2:75.
35. Castano L., Eisenbarth G.S. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990, 8:647-679.
36. Daniel D., Gill R.G., Schloot N., Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 1995, 25:1056-1062.
37. Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., Hering B.J., Hafler D.A. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005, 435:224-228.
38. Levisetti M.G., Suri A., Petzold S.J., Unanue E.R. The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form. J Immunol 2007, 178:6051-6057.
39. Suri A., Levisetti M.G., Unanue E.R. Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?. Curr Opin Immunol 2008, 20:105-110.
40. Stadinski B.D., Zhang L., Crawford F., Marrack P., Eisenbarth G.S., Kappler J.W. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc Natl Acad Sci U S A 2010, 107:10978-10983.
41. Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Piganelli J.D., Barbour G., Bradley B., Crawford F., et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010, 11:225-231.
42. Delong T., Baker R.L., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Barbour G., Bradley B., Haskins K. Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells. Diabetes 2011, 60.
43. Nikoopour E., Sandrock C., Huszarik K., Krougly O., Lee-Chan E., Masteller E.L., Bluestone J.A., Singh B. Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice. J Immunol 2011, 186:3831-3835.
44. Anderton S.M. Post-translational modifications of self antigens: implications for autoimmunity. Curr Opin Immunol 2004, 16:753-758.
45. Wu C.T., Gershwin M.E., Davis P.A. What makes an autoantigen an autoantigen?. Ann N Y Acad Sci 2005, 1050:134-145.
46. Doyle H.A., Mamula M.J. Posttranslational modifications of self-antigens. Ann N Y Acad Sci 2005, 1050:1-9.
47. Petersen J., Purcell A.W., Rossjohn J. Post-translationally modified T cell epitopes: immune recognition and immunotherapy. J Mol Med (Berl) 2009, 87:1045-1051.
48. Champion B.R., Page K.R., Parish N., Rayner D.C., Dawe K., Biswas-Hughes G., Cooke A., Geysen M., Roitt I.M. Identification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells. J Exp Med 1991, 174:363-370.
49. Rasooly L., Rose N.R., Saboori A.M., Ladenson P.W., Burek C.L. Iodine is essential for human T cell recognition of human thyroglobulin. Autoimmunity 1998, 27:213-219.
50. Mannering S.I., Harrison L.C., Williamson N.A., Morris J.S., Thearle D.J., Jensen K.P., Kay T.W., Rossjohn J., Falk B.A., Nepom G.T., et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 2005, 202:1191-1197.
51. He X.L., Radu C., Sidney J., Sette A., Ward E.S., Garcia K.C. Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au. Immunity 2002, 17:83-94.
52. Bankovich A.J., Girvin A.T., Moesta A.K., Garcia K.C. Peptide register shifting within the MHC groove: theory becomes reality. Mol Immunol 2004, 40:1033-1039.
53. Mohan J.F., Levisetti M.G., Calderon B., Herzog J.W., Petzold S.J., Unanue E.R. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol 2010, 11:350-354.
54. Daniel C., Weigmann B., Bronson R., von Boehmer H. Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope. J Exp Med 2011, 208:1501-1510.
55. Gardner J.M., Devoss J.J., Friedman R.S., Wong D.J., Tan Y.X., Zhou X., Johannes K.P., Su M.A., Chang H.Y., Krummel M.F., et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 2008, 321:843-847.